Effectiveness of benzbromarone versus febuxostat in gouty patients: a retrospective study

非布索坦 苯溴马隆 医学 痛风 尿酸 泌尿科 肌酐 内科学 高尿酸血症 胃肠病学 肾功能 内分泌学 药理学
作者
Dongmei Liu,Binbin Zhou,Zhen Li,Zhuojun Zhang,Xiaojuan Dai,Zongfei Ji,Huiyong Chen,Ying Sun,Lindi Jiang
出处
期刊:Clinical Rheumatology [Springer Nature]
卷期号:41 (7): 2121-2128 被引量:1
标识
DOI:10.1007/s10067-022-06110-5
摘要

Benzbromarone and febuxostat use different mechanisms to reduce serum urate. However, the effectiveness of benzbromarone versus febuxostat in reducing serum urate in gouty patients classified with different types of hyperuricaemia remains unclear.In this retrospective study from January 1, 2018, to September 30, 2020, subjects were identified if they were newly treated with benzbromarone 25 mg daily or febuxostat 20 mg daily. The subjects were classified into four types according to their 24-h urinary uric acid and fractional excretion of uric acid. The baseline data and follow-up information after 28 ± 3 days of treatment were collected.Seventy-three subjects with gout were finally enrolled. Among them, 50 were treated with benzbromarone. The percent changes in serum urate from the baseline were - 33.71 ± 13.59% and - 29.45 ± 10.62% in the benzbromarone and febuxostat group, respectively, without a significant difference between the groups (P = 0.188). No differences were found between the groups in subjects classified as the renal underexcretion type, combined type, or "normal" type. In patients with eGFR ≥ 70 mL/min/1.73 m2, the rate of serum urate lowering was higher in those treated with benzbromarone than in those treated with febuxostat. Febuxostat treatment significantly lowered serum creatinine from the baseline (P = 0.001).Benzbromarone 25 mg daily and febuxostat 20 mg daily may have comparable effectiveness in lowering the serum urate among different types of hyperuricaemia. Benzbromarone was more effective than febuxostat in lowering serum urate in subjects with eGFR ≥ 70 mL/min/1.73 m2, while febuxostat had a renal protective effect. Key Points • Benzbromarone 25 mg daily and febuxostat 20 mg daily may have comparable effectiveness in lowering the serum urate in patients with different types of hyperuricaemia. • Benzbromarone 25 mg daily was more effective than febuxostat 20 mg daily in lowering serum urate in subjects with eGFR ≥ 70 mL/min/1.73 m2. • Febuxostat had a renal protective effect after about 1 month treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小匹夫完成签到,获得积分10
刚刚
科研通AI2S应助七_采纳,获得10
3秒前
insissst完成签到,获得积分10
3秒前
枍枫发布了新的文献求助10
3秒前
从容芮应助科研通管家采纳,获得10
3秒前
从容芮应助科研通管家采纳,获得10
4秒前
大模型应助科研通管家采纳,获得10
4秒前
研友_VZG7GZ应助科研通管家采纳,获得10
4秒前
传奇3应助科研通管家采纳,获得10
4秒前
深情安青应助科研通管家采纳,获得10
4秒前
JamesPei应助科研通管家采纳,获得10
4秒前
NexusExplorer应助科研通管家采纳,获得10
4秒前
4秒前
CipherSage应助科研通管家采纳,获得10
4秒前
CipherSage应助Xu_W卜采纳,获得10
4秒前
4秒前
丘比特应助科研通管家采纳,获得10
4秒前
搜集达人应助科研通管家采纳,获得10
4秒前
CipherSage应助科研通管家采纳,获得10
5秒前
大橙子应助科研通管家采纳,获得10
5秒前
深情安青应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
年糕发布了新的文献求助10
6秒前
广隶发布了新的文献求助10
7秒前
小二郎应助韩涵采纳,获得10
9秒前
Altria完成签到,获得积分10
9秒前
10秒前
张宝发布了新的文献求助10
13秒前
14秒前
14秒前
15秒前
GuoZheng发布了新的文献求助10
16秒前
张某完成签到,获得积分20
17秒前
17秒前
机智的皮皮虾完成签到 ,获得积分10
18秒前
21秒前
张某发布了新的文献求助10
22秒前
22秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3161577
求助须知:如何正确求助?哪些是违规求助? 2812863
关于积分的说明 7897487
捐赠科研通 2471775
什么是DOI,文献DOI怎么找? 1316151
科研通“疑难数据库(出版商)”最低求助积分说明 631219
版权声明 602112